Medical device and MedTech insights, news, tips and more

Molekule Launches New Commercial Product, Air Pro RX, with FDA 510(k) Class II Medical Device Clearance

April 29, 2020


Molekule, the leader in reinventing air purification, today announced that the U.S. Food and Drug Administration (FDA) cleared the 510(k) premarket notification for its new medical-grade air purifier, Air Pro RXclassifying it as a 510(k) Class II Medical Device. The Molekule Air Pro RX air purifier is intended for medical purposes to destroy bacteria and viruses in the air and is well-suited for use in operating rooms, emergency department waiting rooms, isolation units, and any critical or high-traffic area in healthcare facilities to provide additional frontline protection. The FDA clearance comes in the midst of the COVID-19 crisis, in which the potential of airborne viruses are becoming of increasing concern.


Air Pro RX uses Molekule’s patented Photo Electrochemical Oxidation (PECO) technology, and has demonstrated greater than 5-log, or 99.999% reduction, of RNA virus MS2 at 24 hours as a proxy virus for SARS-CoV-2. In addition, Air Pro RX meets all applicable performance criteria recommended by the FDA guidelines for use in reducing the spread of SARS-CoV-2 in healthcare settings. Because of PECO technology’s ability to capture and destroy bioaerosols, the device is intended to keep patients and healthcare staff better protected in high-risk areas.

Air Pro RX, along with Molekule Air units, are currently in use at Mercyhealth hospitals across Wisconsin and Illinois.

“It’s critical now more than ever to consider new air purification technology and how it moves medical facility air quality standards forward and protects their patients,” said Jaya Rao, Co-CEO and Co-Founder of Molekule. “With the launch of Air Pro RX and clearance from the FDA, this product allows us to reach those at their most vulnerable. We are incredibly grateful to the FDA for their thorough review process and speed in the midst of the COVID-19 crisis. This FDA clearance enables us to begin to deploy our devices into medical settings immediately.”

See Full Press Release: Molekule Launches New Commercial Product, Air Pro RX, with FDA 510(k) Class II Medical Device Clearance

Written by: Molekule

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.